文献速递免疫规划

复制缺陷型人腺病毒载体19a/64在小鼠与食蟹猴中的免疫原性

Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques.
PubMed 文献 · Vaccine · 2018-09-03

研究设计复制缺陷型hAd19a、hAd5和MVA载体表达乳头瘤病毒抗原与hIi融合蛋白,在小鼠和雌性食蟹猴中评估免疫原性。hAd19a诱导的T细胞应答与hAd5相似,且在存在Ad5预存免疫时未降低;猴中两疫苗诱导CD8+ T细胞效力相当,hAd19a初免组CD4+ T细胞应答更广。

要点

  • hAd19a诱导的T细胞应答与hAd5相似。
  • 小鼠中hAd19a应答在Ad5预存免疫存在时未降低。
  • 猴中hAd19a初免组CD4+ T细胞应答比hAd5更广。

核心结论

  • hAd19a具有作为hAd5替代载体诱导强效PV特异性T细胞应答的潜力。

研究设计与样本

  • 设计复制缺陷型hAd19a、hAd5和MVA载体表达乳头瘤病毒抗原与hIi融合蛋白。
  • 在小鼠和雌性食蟹猴中体内研究免疫原性。

主要发现

  • hAd5中编码的hIi增强小鼠PV特异性CD8+ T细胞应答。
  • hAd19a疫苗接种后诱导的T细胞应答与hAd5疫苗接种相似。
  • 小鼠中存在Ad5预存免疫时hAd19a诱导的应答未降低。
  • 食蟹猴中两疫苗在MVA加强后诱导CD8+ T细胞效力相当。
  • hAd19a初免动物中CD4+ T细胞应答水平更广。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The human adenovirus type 19a/64 (hAd19a) is a rare serotype in the human population that transduces human dendritic cells (DCs) and human muscle cells more efficiently than the well-characterized human adenovirus type 5 (hAd5). To further characterize the potential of this vector as a vaccine we designed replication deficient hAd19a, hAd5 and MVA vectors expressing a papillomavirus (PV) antigen fused to the human MHC class II associated invariant chain T cell adjuvant (hIi) and investigated their immunogenicity in vivo in mice and cynomolgus macaques. We initially showed that the hIi encoded in the hAd5 enhanced PV specific CD8+ T cell responses in mice. The T cell responses induced after hAd19a vaccination was similar to those induced by hAd5 vaccination. The hAd19a induced responses were not reduced in presence of preexisting Ad5 immunity in mice. In macaques both vaccines were equally potent at inducing CD8+ T cells after MVA boost, while the level of CD4+ T cell responses were found to be broader in hAd19a primed animals. These data demonstrate the potential of hAd19a as an alternative vector to hAd5 to elicit potent T cell responses to PV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ragonnaud E, Schroedel S, Mariya S, et al. Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques. Vaccine. 2018. PMID: 30190120. doi:10.1016/j.vaccine.2018.07.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。